Deirdre Lane
Deirdre Lane
University of Liverpool, United Kingdom; Aalborg University, Denmark
Verified email at liverpool.ac.uk
Title
Cited by
Cited by
Year
Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
21151*2014
Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Circulation 131 (4), 434-441, 2015
150412015
Heart disease and stroke statistics—2017 update
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
9262*2017
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial …
GYH Lip, R Nieuwlaat, R Pisters, DA Lane, HJGM Crijns
Chest 137 (2), 263-272, 2010
52112010
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey
R Pisters, DA Lane, R Nieuwlaat, CB De Vos, HJGM Crijns, GYH Lip
Chest 138 (5), 1093-1100, 2010
37342010
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with …
Authors/Task Force Members, SG Priori, C Blomström-Lundqvist, ...
Ep Europace 17 (11), 1601-1687, 2015
27952015
American heart association statistics committee and stroke statistics subcommittee
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Heart disease and stroke statistics-2017 update: a report from the American …, 2017
2538*2017
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz, HC Diener, W Hacke, ...
Ep Europace 17 (10), 1467-1507, 2015
13292015
Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice …
JJ You, DE Singer, PA Howard, DA Lane, MH Eckman, MC Fang, ...
Chest 141 (2), e531S-e575S, 2012
11482012
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
J Steffel, P Verhamme, TS Potpara, P Albaladejo, M Antz, L Desteghe, ...
European heart journal 39 (16), 1330-1393, 2018
9692018
Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver …
GYH Lip, L Frison, JL Halperin, DA Lane
Journal of the American College of Cardiology 57 (2), 173-180, 2011
9442011
Stroke and bleeding in atrial fibrillation with chronic kidney disease
JB Olesen, GYH Lip, AL Kamper, K Hommel, L Køber, DA Lane, ...
New England Journal of Medicine 367 (7), 625-635, 2012
7572012
Quality of life in patients with atrial fibrillation: a systematic review
G Thrall, D Lane, D Carroll, GYH Lip
The American journal of medicine 119 (5), 448. e1-448. e19, 2006
7332006
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a …
Task Force Members, GYH Lip, S Windecker, K Huber, P Kirchhof, ...
European heart journal 35 (45), 3155-3179, 2014
5762014
Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety
D Lane, D Carroll, C Ring, DG Beevers, GYH Lip
Psychosomatic medicine 63 (2), 221-230, 2001
5752001
Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation …
GYH Lip, L Frison, JL Halperin, DA Lane
Stroke 41 (12), 2731-2738, 2010
5462010
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’nationwide cohort study
JB Olesen, GYH Lip, J Lindhardsen, DA Lane, O Ahlehoff, ML Hansen, ...
Thrombosis and haemostasis 106 (10), 739-749, 2011
5062011
Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED bleeding risk–prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (Evaluating …
S Apostolakis, DA Lane, Y Guo, H Buller, GYH Lip
Journal of the American College of Cardiology 60 (9), 861-867, 2012
3902012
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a'real world'atrial fibrillation population: a modelling analysis …
A Banerjee, DA Lane, C Torp-Pedersen, GYH Lip
Thrombosis and haemostasis 107 (3), 584, 2012
3692012
Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation
DA Lane, GYH Lip
Circulation 126 (7), 860-865, 2012
3682012
The system can't perform the operation now. Try again later.
Articles 1–20